Skip to main content
. 2021 Sep 3;35(5):2821–2829. doi: 10.21873/invivo.12569

Figure 6. Neutrophil to lymphocyte ratio (NLR) before and after first-line chemotherapy for patients treated with reduced-dose gemcitabine plus cisplatin (GC-r, n=10) or full-dose gemcitabine plus carboplatin (G-Car-f, n=24). p-Values were determined by the Wilcoxon ranked sign test.

Figure 6